PT  - JOURNAL ARTICLE
AU  - Miguel Navascués
AU  - Costantino Budroni
AU  - Yelena Guryanova
TI  - Disease control as an optimization problem
AID  - 10.1101/2020.09.15.20194811
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2020.09.15.20194811
4099  - http://medrxiv.org/content/early/2021/03/01/2020.09.15.20194811.short
4100  - http://medrxiv.org/content/early/2021/03/01/2020.09.15.20194811.full
AB  - Traditionally, expert epidemiologists devise policies for disease control through a mixture of intuition and brute force. Namely, they use their know-how to narrow down the set of logically conceivable policies to a small family described by a few parameters, following which they conduct a grid search to identify the optimal policy within the set. This scheme is not scalable, in the sense that, when used to optimize over policies which depend on many parameters, it will likely fail to output an optimal disease policy in time for its implementation. In this article, we use techniques from convex optimization theory and machine learning to conduct optimizations over disease policies described by hundreds of parameters. In contrast to past approaches for policy optimization based on control theory, our framework can deal with arbitrary uncertainties on the initial conditions and model parameters controlling the spread of the disease. In addition, our methods allow for optimization over weekly-constant policies, specified by either continuous or discrete government measures (e.g.: lockdown on/off). We illustrate our approach by minimizing the total time required to eradicate COVID-19 within the Susceptible-Exposed-Infected-Recovered (SEIR) model proposed by Kissler et al. (March, 2020).Competing Interest StatementThe authors have declared no competing interest.Funding StatementC.B. and Y.G. acknowledge funding from the Austrian Science Fund (FWF) through the Zukunftskolleg ZK03. None of the authors received payment or services from a third party.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research is mathematical, so no ethics committee approvals were needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSoon we will make our computer codes available.